Description: Like it or not, variable annuity (VA) liabilities are inextricably linked with the equity markets. Generally, up markets reduce the excess benefit liability and increase fee income, while down markets increase the excess benefit liability and reduce fee income. Given the volatility, most VA writers will hedge to meet their needs. In this session, the presenters will discuss the need for hedging, regulatory requirements and how companies ultimately determine their hedging strategies.

Description: 2021 Life Meeting - Session 7D: Emerging Trends in Lapse and Mortality for Life Products 9.1.21 Recording

Description: Throughout this session, the presenters will focus on tax rules pertaining to life and annuities, highlighting the recent changes to interest rates under Internal Revenue Code Section 7702 which determines whether a contract qualifies as a life insurance contract. In addition, recent annuity changes will be discussed such as required minimum distributions. Background and examples will be provided on the cash value accumulation test, the guideline premium requirements and the cash value corridor rules under 7702.

Description: Join us for this popular annual webcast covering the latest considerations for the year's U.S. statutory financial reporting work. Get ready to hear from three expert speakers, who will discuss cash flow testing and this year’s New York and California holiday letters, the impact of recent interest rate changes including treatment of negative IMR, potential changes to statutory financial reporting due to climate change, and updates regarding Principle Based Reserves.

Description: Insurers are increasingly using advanced analytics to model expected outcomes. Two well-known examples in the life insurance industry are models for predicting policyholder behavior and to manage risk selection. The presenters will explore the various types of advanced analytics being considered in models and how the associated risks of these models can be incorporated into an enterprise's risk framework.

Description: 2021 Life Meeting - Session 8D: Three Years After Model Conversion: How’s it Going? 9.1.21 Recording

Description: An updated ASOP No. 2 will be effective June 1, 2022, for nonguaranteed element (NGEs) determination for life and annuity products. Join this roundtable discussion on the considerations around the revisions to ASOP No. 2, including topics as: NGE framework - an actuary’s role in setting NGE policy - pricing factors for NGEs on new products - considerations when contemplating changing NGEs under the new ASOP - value of the revised ASOP No. 2 in NGE determinations, reviews and revisions

Description: Pricing is a central activity of actuaries to assure solvency and to manage risk. Life insurance is also a social good, not just a product, and the US population is massively underinsured. Pricing must strike a balance. Unlike a simple 4x4 matrix to produce pricing, today's technology offers the ability to evaluate literally thousands of variables, enabling a kind of precision pricing. It also heightens the possibility of introducing bias and discrimination through the use of unregulated third-party data.

Description: In order for an organization to benefit from artificial intelligence/machine learning (AI/ML) models, it requires the involvement of different business areas. During this webcast, professionals from data analytics, audit and risk areas will address challenges and provide solutions for working together to develop, implement, use and risk manage AI/ML tools. Throughout the discussion, the presenters will discuss: • Defining and exploring the challenges and objectives between data scientists, domain experts and control functions • Risk management – model risks and other risks • End-to-end model validation • Model performance vs. interpretability/understandability trade-offs • What to audit – auditor’s challenge and solutions

Description: Risk adjustment in government regulated health plans has been around for over two decades. Yet the strategies for promoting risk score accuracy haven't varied much during that time. Most health plans, physician groups, and vendors promote chart reviews and/or in-home assessments as the primary vehicle for collecting data not perceived to be present in the routine claims submission and adjudication stream. We know that most organizations trying to coalesce encounter data from multiple sources often fail to ensure that all relevant data is ultimately submitted to CMS or a state Medicaid agency. Crucial data, often with significant financial value, frequently gets lost in the data pipeline, somewhere between the provider's billing system and the health plan and/or its vendors. Because 837-formatted data is difficult to read, it complicates payers and vendor’s abilities to track encounter data so that every service delivered to patients is credited to the applicable risk adjustment formula. It is incumbent upon successful risk-adjusted entities to be able to track encounter data, identify processes and/or vendors which may be mangling or losing data, in order to ensure that risk scores are sufficiently accurate to be compliant with plan sponsor requirements and to ensure appropriate revenue to the health plan or provider group.